BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 24619059)

  • 1. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
    Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
    Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Light chain deposition disease. Experience in our environment].
    Martín Herrera C; Suñer Poblet M; Cabrera R; Díaz Pedrero M; Fernández Alonso J
    Nefrologia; 2008; 28(5):539-42. PubMed ID: 18816213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease.
    Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K
    Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic heterogeneity of renal light-chain deposition disease.
    Gokden N; Barlogie B; Liapis H
    Ultrastruct Pathol; 2008; 32(1):17-24. PubMed ID: 18300034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
    Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F
    Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin light-chain toxicity in a mouse model of monoclonal immunoglobulin light-chain deposition disease.
    Bender S; Ayala MV; Bonaud A; Javaugue V; Carrion C; Oblet C; Rinsant A; Kaaki S; Oruc Z; Boyer F; Paquet A; Pons N; Hervé B; Ashi MO; Jaccard A; Delpy L; Touchard G; Cogné M; Bridoux F; Sirac C
    Blood; 2020 Oct; 136(14):1645-1656. PubMed ID: 32559766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis.
    Said SM; Best Rocha A; Valeri AM; Paueksakon P; Dasari S; Theis JD; Vrana JA; Obadina MO; Saghafi D; Alexander MP; Sethi S; Larsen CP; Joly F; Dispenzieri A; Bridoux F; Sirac C; Leung N; Fogo AB; McPhail ED; Nasr SH
    Kidney Int; 2022 Jan; 101(1):152-163. PubMed ID: 34767832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
    Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease.
    Cohen C; Royer B; Javaugue V; Szalat R; El Karoui K; Caulier A; Knebelmann B; Jaccard A; Chevret S; Touchard G; Fermand JP; Arnulf B; Bridoux F
    Kidney Int; 2015 Nov; 88(5):1135-43. PubMed ID: 26176826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light chain deposition disease masquerading as smoking-associated nodular glomerulosclerosis with deposits identified by electron microscopy only.
    Alom MS; Grewal R; Passero FC; Goldman B; Choung HYG
    CEN Case Rep; 2022 Nov; 11(4):448-452. PubMed ID: 35316527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
    Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
    Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light chain nephropathy: histological and clinical aspects in 15 cases.
    Confalonieri R; Barbiano di Belgiojoso G; Banfi G; Ferrario F; Bertani T; Pozzi C; Casanova S; Lupo A; De Ferrari G; Minetti L
    Nephrol Dial Transplant; 1988; 3(2):150-6. PubMed ID: 3140081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of renal transplantation in light-chain deposition disease.
    Leung N; Lager DJ; Gertz MA; Wilson K; Kanakiriya S; Fervenza FC
    Am J Kidney Dis; 2004 Jan; 43(1):147-53. PubMed ID: 14712438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-crystalline light chain proximal tubulopathy, a morphologically protean entity.
    Kousios A; Blakey S; Moran L; Atta M; Charif R; Duncan N; Smith A; Tam FWK; Levy JB; Chaidos A; Roufosse C
    Nephrol Dial Transplant; 2023 Oct; 38(11):2576-2588. PubMed ID: 37120733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
    Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
    Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.
    Joly F; Cohen C; Javaugue V; Bender S; Belmouaz M; Arnulf B; Knebelmann B; Nouvier M; Audard V; Provot F; Gnemmi V; Nochy D; Goujon JM; Jaccard A; Touchard G; Fermand JP; Sirac C; Bridoux F
    Blood; 2019 Feb; 133(6):576-587. PubMed ID: 30578255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kidney involvement in light-chain deposition disease].
    Merta M; Rysavá R; Zabka J; Stejskalová A; Vernerová Z; Haber J; Spicka I; Tesar V; Klener P
    Sb Lek; 2002; 103(3):397-403. PubMed ID: 12688183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.